Page 4 - Corona Remedies

Steep hike in fares on India-US flights after 'do not travel' US advisory

Average fare for an economy class ticket on a India-US flight is around Rs 50,000, but the fares for this week's flights are hovering around Rs 150,000

What medicines should you take if you have Covid-19? Let's find out

Covid-19: Man caught with 12 vials of Remdesivir injections in Mumbai

A 22-year-man was caught with a dozen vials of Remdesivir, a key medicine in treatment of coronavirus, said police on Friday

Delhi records over 4,000 Covid-19 cases, highest single-day spike this year

The city had reported 3,567 cases on Saturday and 3,594 cases on Friday

Why did govt extend the interval between Covishield doses to 8 weeks?

The government has increased the time interval between the two doses of Covishield - the Oxford-AstraZeneca vaccine against Covid-19, from four-six weeks to four-eight weeks

Patanjali's Coronil, 1st 'proof-based' drug to fight Covid, gets govt nod

Ramdev-led Patanjali Ayurved had launched 'Coronil', for treating Covid-19 on June 23

Indian scientists find new drugs that can potentially treat coronavirus

Indian scientists have identified drugs and possible cocktails that can target vital proteins of the novel coronavirus, and may potentially help treat Covid-19

Coronavirus vaccine update: UK, Russia to rollout vaccine from next week

UK has become the first country to approve Pfizer coronavirus vaccine for rollout. Russia, India, Oxford vaccine are also making some progress. Catch latest coronavirus vaccine updates here

Alcohol-free sanitiser just as effective as alcohol-based one against Covid

A new study from researchers at Brigham Young University finds that alcohol-free hand sanitiser is just as effective at disinfecting surfaces from the Covid-19 virus as alcohol-based products

Scientists call for study of mucosal immune system's role in curbing Covid

Mucous membranes of the nose and mouth might play a "significant role" in curbing the spread of Covid-19, say scientists

Co-morbidity, genetic factors heighten risk of severe Covid-19: Study

A new study led by researchers from Beth Israel Deaconess Medical Center sheds light on the genetic risk factors that make individuals more or less susceptible to severe Covid-19

Coronavirus vaccine: How much it costs, who'll get it first and other FAQs

From Moderna, Pfizer to Oxford and Bharat Biotech coronavirus vaccine candidates, here's all you need to know about Covid-19 shots, who gets them first and what their cost may be

Nasal spray to protect against coronavirus ready for use in humans

A nasal spray that can provide effective protection against the Covid-19 has been developed by researchers at the University of Birmingham, using materials already cleared for use in humans

Coronavirus vaccine update: China Covid vaccine gives quick immune response

Moderna has joined Pfizer in approaching the Covid-19 vaccine finish line. Russia, India and Oxford vaccine are also making progress. Catch latest coronavirus vaccine updates and corona treatment here

Global Covid-19 cases surpass 50 million: Johns Hopkins University

Global cases Covid-19 surpassed 50 million, according to the Center for Systems Science and Engineering at Johns Hopkins University

Issue directions to ban disinfectants, UV ray use on humans: SC to Centre

The Supreme Court asked the Centre to issue directions for banning use of disinfectants and ultra violet rays on humans for Covid-19 management

India's Covid-19 caseload mounts to over 8.3 million with 50,210 new cases

India's Covid-19 tally climbed to 8.3 million with 50,210 new cases in a day, while 7.7 million people have recuperated so far, pushing the national recovery rate to 92.20%

Scientists identify Covid patients who recover quickly, sustain antibodies

Researchers have found that a subset of Covid-19 patients who recover faster have a persistent antibody response against the novel coronavirus

Coronavirus vaccine update: Mexico gets 1st doses of Chinese vaccine COVAX

Two coronavirus vaccine frontrunners - Pfizer and Moderna - are set to release late-stage and Phase-II results this month. Catch latest coronavirus vaccine updates here

Aspen Pharmacare, Johnson & Johnson announce deal to make Covid-19 vaccine

South African pharmaceutical firm Aspen Pharmacare has announced a deal with U.S. firm Johnson & Johnson to manufacture its COVID-19 vaccine candidate, if it is approved in South Africa and internationally. In a statement issued on Monday, Aspen said that if ongoing trials bring international health authorities to endorse the J&J vaccine as effective and safe, it would be produced at Aspen's manufacturing facility in Port Elizabeth in South Africa's Eastern Cape province. The company said the facility has a capacity to manufacture more than 300 million doses of the vaccine a year. Johnson & Johnson's test vaccine, Ad26.COV3-S, is one of four different vaccines currently undergoing clinical trials in South Africa. Johnson & Johnson would be responsible for supplying the vaccine in large batches and Aspen would put it into vials and package it for individual doses, pending a final commercial agreement, said the statement issued by Aspen. Aspen chief executive Stephen ...